A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis
Chavoustie, Steven E, Gersten, Janet K, Samuel, Milroy J, Schwebke, Jane R
Published in Journal of women's health (Larchmont, N.Y. 2002) (01.04.2018)
Published in Journal of women's health (Larchmont, N.Y. 2002) (01.04.2018)
Get more information
Journal Article